Boston University

Graham Hancock and 'alternative researchers' claim The Sphinx could be at least 12,500 years old, sparking 'archaeology wars' with the academic establishment. Hancock believes in a lost Ice Age civilisation of seafaring shamans using psychedelics, which influenced ancient sites like The Sphinx and megalithic temples, challenging conventional wisdom.

Massachusetts leads in biotech innovation, focusing on sustainability. Universities, research institutions, and companies drive advancements, with government support fostering a cohesive ecosystem. Key innovations include biodegradable plastics, sustainable agriculture, and clean energy solutions. Challenges remain in funding and regulation, but continued collaboration and education are vital for future leadership.

Livia Fernandes, a biotechnology alumna of Middlesex Community College, returned as an Assistant Professor in 2024. Born in Brazil, she overcame language barriers and pursued her degree at MCC, switching from biology to biotechnology. Her experience at MCC, including internships and flexible scheduling, led to a successful career in biopharma. Now, she aims to foster interactive learning and prepare students for the biotech industry.

New research shows death rates among homeless people in Clark County, Nevada, and Los Angeles County, California, rise with higher temperatures, especially above 90°F. The study, published in the American Journal of Epidemiology, highlights the increased risk for the homeless during extreme heat and cold, emphasizing the need for more cooling centers and stable housing.

BU researchers are working to diagnose CTE in life through the Bank CTE study, aiming to identify biomarkers in blood samples and correlate them with postmortem brain findings, potentially transforming CTE into a treatable disease.

Calluna Pharma appoints Mark Gaffney as CEO; Gaffney brings 20+ years of experience in biotech, previously CEO of Oxular Limited and COO at Vedere Bio (acquired by Novartis). Gaffney will lead Calluna's strategy as CAL101 completes Phase 1 this year.

Most vendors of synthetic nicotine vapes on Instagram ignore FDA health warnings, potentially exposing kids to harmful products. Synthetic nicotine, not derived from tobacco, evaded FDA regulation until 2022, allowing flavored products appealing to youth. Despite FDA mandates, only 13% of Instagram ads for synthetic nicotine vapes comply with health warning requirements.

Dean ad interim Elise Morgan awarded Rhonda Harrison (’98, ’04) and Bob Hines (’97) the 2024 Distinguished Alumni Award at BU’s RASTIC, recognizing their significant contributions to bioinformatics and space exploration, respectively.

The FDA approved Bristol Myers Squibb's Cobenfy, a new schizophrenia treatment with fewer side effects like drowsiness and weight gain, though it has its own adverse effects such as nausea and constipation. Researchers are cautiously optimistic about its potential, noting the need for head-to-head comparisons with existing antipsychotics to determine its superiority. The drug's high cost may limit its accessibility, despite being covered by Medicare or Medicaid for most eligible patients.

The Arthritis Foundation awarded $150,000 each to Cara Lewis and Michael Willey/Jessica Goetz for FastOA research on hip OA risk in young female athletes and post-surgical hip dysplasia patients, respectively.